Cargando…
Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation
Significant advancements have been achieved in the area of molecular targeted therapy for lung adenocarcinoma (LUAD). However, the complex molecular patterns and high heterogeneity of LUAD confine the efficacy of these therapies to a specific subset of patients; therefore, it is necessary to explore...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433705/ https://www.ncbi.nlm.nih.gov/pubmed/37539739 http://dx.doi.org/10.3892/mmr.2023.13064 |